Should U.S. women be screened for cervical cancer with Pap tests, HPV tests or both? According to researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) while the merits of screening ...
Jun 9, 2014
0
2
U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.
Apr 24, 2014
0
0
A high-tech screening tool for cervical cancer is facing pushback from more than a dozen American patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: ...
Apr 15, 2014
0
0
(HealthDay)—The Pap test has been a routine gynecological procedure for generations of American women. But on Wednesday, a Food and Drug Administration advisory panel is considering whether to delay the Pap test and use ...
Mar 12, 2014
0
0
A new study finds that female-to-male (FTM) transgender patients had over 10 times higher odds of having an inadequate Papanicolaou (Pap) test compared to female patients. The findings, by Fenway Health's Jennifer Potter, ...
Jan 15, 2014
1
0
For the past ten years, clinicians throughout the United States have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women, according to a researcher from Huntsman Cancer Institute ...
Nov 25, 2013
0
0
For low-risk women, the likelihood that they get tested for the infection that causes cervical cancer (human papillomavirus or HPV) may depend on what clinic they visit, their doctor's status and whether their provider is ...
Nov 7, 2013
0
0
(HealthDay)—The top five gynecologic oncology-related issues that physicians and patients should question have been released by the Society of Gynecologic Oncology (SGO) as part of the Choosing Wisely campaign.
Nov 6, 2013
0
0
(HealthDay)—When doctors think about tests that might cause sticker shock for their patients, they wouldn't normally consider a simple Pap smear.
Oct 16, 2013
0
0
A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type's molecular idiosyncrasies.
Aug 23, 2013
0
0
